These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37993894)

  • 21. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uncovering heterogeneous cognitive trajectories in mild cognitive impairment: a data-driven approach.
    Wang X; Ye T; Zhou W; Zhang J;
    Alzheimers Res Ther; 2023 Mar; 15(1):57. PubMed ID: 36941651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.
    Nation DA; Ho JK; Dutt S; Han SD; Lai MHC;
    J Alzheimers Dis; 2019; 69(4):1171-1182. PubMed ID: 31104015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global cognitive trajectory patterns in Alzheimer's disease.
    Cohen CI; Reisberg B; Yaffee R
    Int Psychogeriatr; 2024 Mar; 36(3):200-209. PubMed ID: 35331359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-Administered Gerocognitive Examination: longitudinal cohort testing for the early detection of dementia conversion.
    Scharre DW; Chang SI; Nagaraja HN; Wheeler NC; Kataki M
    Alzheimers Res Ther; 2021 Dec; 13(1):192. PubMed ID: 34872596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline.
    Hochstetler H; Trzepacz PT; Wang S; Yu P; Case M; Henley DB; Degenhardt E; Leoutsakos JM; Lyketsos CG
    J Alzheimers Dis; 2016; 50(1):271-82. PubMed ID: 26639960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's disease biomarkers as predictors of trajectories of depression and apathy in cognitively normal individuals, mild cognitive impairment, and Alzheimer's disease dementia.
    Banning LCP; Ramakers IHGB; Rosenberg PB; Lyketsos CG; Leoutsakos JS;
    Int J Geriatr Psychiatry; 2021 Jan; 36(1):224-234. PubMed ID: 32869375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes Mellitus and Cognition: Pathway Analysis in the MEMENTO Cohort.
    Frison E; Proust-Lima C; Mangin JF; Habert MO; Bombois S; Ousset PJ; Pasquier F; Hanon O; Paquet C; Gabelle A; Ceccaldi M; Annweiler C; Krolak-Salmon P; Béjot Y; Belin C; Wallon D; Sauvee M; Beaufils E; Bourdel-Marchasson I; Jalenques I; Chupin M; Chêne G; Dufouil C;
    Neurology; 2021 Aug; 97(8):e836-e848. PubMed ID: 34210821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective Evaluation of Cognitive Health and Related Factors in Elderly at Risk for Developing Alzheimer's Dementia: A Longitudinal Cohort Study.
    Udeh-Momoh C; Price G; Ropacki MT; Ketter N; Andrews T; Arrighi HM; Brashear HR; Robb C; Bassil DT; Cohn M; Curry LK; Su B; Perera D; Giannakopoulou P; Car J; Ward HA; Perneczky R; Novak G; Middleton L
    J Prev Alzheimers Dis; 2019; 6(4):256-266. PubMed ID: 31686098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex differences in Alzheimer's disease: plasma MMP-9 and markers of disease severity.
    Tsiknia AA; Sundermann EE; Reas ET; Edland SD; Brewer JB; Galasko D; Banks SJ;
    Alzheimers Res Ther; 2022 Nov; 14(1):160. PubMed ID: 36324151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polypharmacy is associated with functional decline in Alzheimer's disease and Lewy body dementia.
    Borda MG; Castellanos-Perilla N; Tovar-Rios DA; Oesterhus R; Soennesyn H; Aarsland D
    Arch Gerontol Geriatr; 2021; 96():104459. PubMed ID: 34225098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of CSF Aβ
    Cullen N; Janelidze S; Palmqvist S; Stomrud E; Mattsson-Carlgren N; Hansson O;
    Neurology; 2022 Mar; 98(9):e958-e967. PubMed ID: 34937781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health-related quality of life in subjective cognitive decline and mild cognitive impairment: a longitudinal cohort analysis.
    Aye S; Bouteloup V; Tate A; Wimo A; Handels R; Jean D; Winblad B; Jönsson L
    Alzheimers Res Ther; 2023 Nov; 15(1):200. PubMed ID: 37968734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tau levels are higher in objective subtle cognitive decline but not subjective memory complaint.
    Thomas KR; Weigand AJ; Edwards LC; Edmonds EC; Bangen KJ; Ortiz G; Walker KS; Bondi MW;
    Alzheimers Res Ther; 2022 Aug; 14(1):114. PubMed ID: 35996158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trajectories of cognitive decline in Alzheimer's disease.
    Wilkosz PA; Seltman HJ; Devlin B; Weamer EA; Lopez OL; DeKosky ST; Sweet RA
    Int Psychogeriatr; 2010 Mar; 22(2):281-90. PubMed ID: 19781112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical AD predicts decline in memory and executive functions in subjective complaints.
    van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM
    Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study partner-reported decline identifies cognitive decline and dementia risk.
    Nosheny RL; Jin C; Neuhaus J; Insel PS; Mackin RS; Weiner MW;
    Ann Clin Transl Neurol; 2019 Dec; 6(12):2448-2459. PubMed ID: 31721455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of ageing.
    Pietrzak RH; Lim YY; Ames D; Harrington K; Restrepo C; Martins RN; Rembach A; Laws SM; Masters CL; Villemagne VL; Rowe CC; Maruff P;
    Neurobiol Aging; 2015 Mar; 36(3):1231-8. PubMed ID: 25585532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Greater Variability in Cognitive Decline in Lewy Body Dementia Compared to Alzheimer's Disease.
    Giil LM; Aarsland D
    J Alzheimers Dis; 2020; 73(4):1321-1330. PubMed ID: 31903991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.